SAT-150-Validation of Korean stroop test in the screening of minimal hepatic encephalopathy

Yoon, Eileen L.; Jun, Dae Won; Jeong, Jaeyoon; Kim, Tae Yeob; Song, Do Seon; Ahn, Sang Bong; Kim, Hee Yeon; Jung, Young Kul; Song, Myeong Jun; Kim, Sung Eun; Kim, Hyoung Su; Jeong, Soung Won; kim, sang gyune; Lee, Tae Hee; Cho, Yong Kyun

doi:10.1016/s0618-8278(19)31389-1

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A Korean Stroop test was developed, and a recent study showed that the Korean Stroop test is valid for diagnosing MHE (area under the curve, 0.74; 95% CI, 0.66-0.83, P<0.001). 331 The Korean Stroop test is available at http://encephalopathy.or.kr/inspection. 326…”

Section: Stroop Testmentioning

confidence: 99%

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

2020

Clin Mol Hepatol

View full text Add to dashboard Cite

clinical practice. Therefore, these revised guidelines for the treatment of varices and HE are offered for Korean practice to reflect the latest research results and extensive discussions within the revision committee. This guideline contains the opinions of experts and is intended to be a practical reference for the care of patients with varices and HE; it is not an absolute standard of care. The best choices for each patient's care vary from case to case, and the judgment of the doctor in charge is important. As medical evidence and new findings accumulate in the future, these guidelines will require ongoing supplementation and revision. This guideline may not be modified or altered without permission. Target population This guideline discusses patients with varices, HE, and related complications (esophageal varices [EVs] and bleeding, gastric varices and bleeding, portal hypertensive gastropathy, covert and overt HE) caused by liver cirrhosis. It is intended for clinicians and other medical personnel who are in charge of diagnosing and treating patients with liver cirrhosis. This guideline is also intended to provide practical clinical and educational information and directions for resident physicians and fellows in training, practitioners, and their trainers and supervisors. Development, funding, and revision process Comprising 14 hepatologists, the Clinical Practice Guideline Committee for Liver Cirrhosis: Varices, HE, and related complications (the Committee) was organized by the KASL Board of Executives. Funding for the revisions was provided by KASL. Each committee member collected and analyzed source data in his or her own field, and the members then wrote the manuscript together. Literature review The Committee selected keywords and questions using PICO (Patient/Problem, Intervention, Comparison, Outcome) assessments and systematically collected and reviewed international and domestic literature available in PubMed, MEDLINE, Kore-aMed, the Korean Medical Database, and other databases. In addition to published articles, abstracts of important meetings published before January 2019 were evaluated.

show abstract

Section: Stroop Testmentioning

confidence: 99%

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

2020

Clin Mol Hepatol

View full text Add to dashboard Cite

show abstract

SAT-150-Validation of Korean stroop test in the screening of minimal hepatic encephalopathy

Cited by 1 publication

References 0 publications

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Contact Info

Product

Resources

About